financetom
Business
financetom
/
Business
/
Coinbase Stock a Buy Opportunity Following Thursday's 'Overdone' Selloff, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coinbase Stock a Buy Opportunity Following Thursday's 'Overdone' Selloff, Oppenheimer Says
May 26, 2025 9:43 AM

02:25 PM EDT, 05/16/2025 (MT Newswires) -- A recent selloff in Coinbase Global's ( COIN ) shares following a cyberattack announcement and news about a regulatory probe has created a buying opportunity for the stock, Oppenheimer said in a note e-mailed Friday.

The cryptocurrency exchange on Thursday disclosed a recent cyberattack that it said could cost the company $180 million to $400 million due to remediation actions and customer reimbursements. Separately, The New York Times reported about a US Securities and Exchange Commission investigation into a Coinbase user metric.

Shares of the company slumped 7.2% Thursday, but were rallying 9.1% intraday Friday.

"While these headlines have impacted near-term sentiment, they haven't changed our long-term view on the stock," Oppenheimer analysts Owen Lau and Guru Sidaarth wrote in the note. "We believe the sell-off is overdone."

The brokerage reiterated its outperform rating on the stock, with a $293 price target.

Coinbase, which is set to join the S&P 500 Monday, said Thursday that the affected data included names, addresses, phones and e-mails of clients, though the incident did not involve a compromise of passwords or private keys.

The cyberattack was "an unfortunate event which impacts the reputation of (Coinbase), but it appears to be an isolated case," Lau and Sidaarth said. It affected less than 1% of Coinbase's monthly transacting users, while most of the financial impact will likely be incurred in the second quarter, they said.

The SEC investigation is a hold-over probe about the verified users metric that the company stopped reporting two and a half years ago, Coinbase Chief Legal Officer Paul Grewal told MT Newswires. Grewal emphasized that this investigation shouldn't continue, but the market likely "read it differently, particularly after the cyberattack announcement," according to the Oppenheimer note.

Price: 266.19, Change: +21.75, Percent Change: +8.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved